Article thumbnail

NMDA Mediated Contextual Conditioning Changes miRNA Expression

By Min Jeong Kye, Pierre Neveu, Yong-Seok Lee, Miou Zhou, Judith A. Steen, Mustafa Sahin, Kenneth S. Kosik and Alcino J. Silva

Abstract

We measured the expression of 187 miRNAs using quantitative real time PCR in the hippocampal CA1 region of contextually conditioned mice and cultured embryonic rat hippocampal neurons after neuronal stimulation with either NMDA or bicuculline. Many of the changes in miRNA expression after these three types of stimulation were similar. Surprisingly, the expression level of half of the 187 measured miRNAs was changed in response to contextual conditioning in an NMDA receptor-dependent manner. Genes that control miRNA biogenesis and components of the RISC also exhibited activity induced expression changes and are likely to contribute to the widespread changes in the miRNA profile. The widespread changes in miRNA expression are consistent with the finding that genes up-regulated by contextual conditioning have longer 3′ UTRs and more predicted binding sites for miRNAs. Among the miRNAs that changed their expression after contextual conditioning, several inhibit inhibitors of the mTOR pathway. These findings point to a role for miRNAs in learning and memory that includes mTOR-dependent modulation of protein synthesis

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3171446
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A brain-specific microRNA regulates dendritic spine development.
  2. (2009). A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation.
  3. (2009). A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.
  4. (2010). A novel pathway regulates memory and plasticity via SIRT1 and miR-134.
  5. (2011). A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences
  6. (2010). Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
  7. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model.
  8. (2010). Altered histone acetylation is associated with age-dependent memory impairment in mice.
  9. (2006). Amygdala regulation of immediate-early gene expression in the hippocampus induced by contextual fear conditioning.
  10. (2008). An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP.
  11. (2006). Cell-type-specific signatures of microRNAs on target mRNA expression.
  12. (2009). Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB.
  13. (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
  14. (2011). Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex.
  15. (2004). Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization.
  16. (2010). Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
  17. (2006). Dendritic protein synthesis, synaptic plasticity, and memory.
  18. (2010). Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
  19. (2009). Fine-tuning neural gene expression with microRNAs.
  20. (2010). Fragile X protein family member FXR1P is regulated by microRNAs.
  21. (2010). Identification of the miR-106b,25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.
  22. (2001). Inducible, pharmacogenetic approaches to the study of learning and memory.
  23. (2010). Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/ CREB pathways.
  24. (1964). Loss of Recent Memory in Mice as Related to Regional Inhibition of Cerebral Protein Synthesis.
  25. (2008). Macromolecular synthesis, distributed synaptic plasticity, and fear conditioning.
  26. (2009). Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring.
  27. (2008). Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight?
  28. (2005). microPrimer: the biogenesis and function of microRNA.
  29. (2009). MicroRNA as modulators of neuronal responses.
  30. (2010). MicroRNA loss enhances learning and memory in mice.
  31. (2011). MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression.
  32. (2010). MicroRNA profiling during mouse ventricularmaturation: a role for miR-27 modulatingMef2c expression. Cardiovasc Res.
  33. (2009). MicroRNA regulation of Alzheimer’s Amyloid precursor protein expression.
  34. (2010). MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci.
  35. (2010). MicroRNA-21 (miR21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
  36. (2010). MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes.
  37. (2010). MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization.
  38. (2010). MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes.
  39. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
  40. (2009). MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor proteinconverting enzyme 1.
  41. (2010). MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia.
  42. (2010). MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.
  43. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
  44. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function.
  45. (2010). miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-beta type II receptor.
  46. (2010). miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.
  47. (2010). miR-10b targets Tiam1: implications for Rac activation and carcinoma migration.
  48. (2008). miR-148 targets human DNMT3b protein coding region.
  49. (2009). miR-19 is a key oncogenic component of mir-17-92.
  50. (2010). miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics.
  51. (2009). miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to ‘‘seedless" 39UTR microRNA recognition elements.
  52. (2009). miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
  53. (2009). miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
  54. (2009). miR139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes.
  55. (2010). miR148 regulates Mitf in melanoma cells.
  56. (2010). miR204 is required for lens and retinal development via Meis2 targeting.
  57. (2010). miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging
  58. (2009). Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression.
  59. (2006). Neuroscience gears up for duel on the issue of brain versus deity.
  60. (2009). Nicotine modulates expression of miR-140*, which targets the 39-untranslated region of dynamin 1 gene (Dnm1).
  61. (2010). Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.
  62. (2010). RISC activity in hippocampus is essential for contextual memory.
  63. (2008). RISC-target interaction: cleavage and translational suppression.
  64. (2010). Schizophrenia is associated with an increase in cortical microRNA biogenesis.
  65. (2011). Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage.
  66. (2007). Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR.
  67. (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
  68. (2006). Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila.
  69. (2008). Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation.
  70. (2009). TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.
  71. (2009). The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing.
  72. (2008). The immediate early gene arc/arg3.1: regulation, mechanisms, and function.
  73. (2008). The impact of microRNAs on protein output.
  74. (2004). The Microprocessor complex mediates the genesis of microRNAs.
  75. (2009). The miR-302-367 cluster as a potential stemness regulator in ESCs.
  76. (2009). The molecular and cellular biology of enhanced cognition.
  77. (2009). The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.
  78. (2009). Translational control of long-lasting synaptic plasticity and memory.
  79. (2008). Tuberous sclerosis complex proteins control axon formation.
  80. (2010). Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
  81. (2008). Widespread changes in protein synthesis induced by microRNAs.